Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Current assets:
Cash and cash equivalents	$ 65,064	$ 39,760
Marketable securities	79,738	53,074
Accounts receivable (net of allowance of $35 and $127 at December 31, 2015 and 2014 respectively)	6,978	1,679
Inventories	4,155	6,729
Research and development tax credit receivable - current portion	2,382	5,932
Prepaid expenses and other current assets	7,989	4,418
Current assets held for sale	0	730
Total current assets	166,306	112,322
Property and equipment, net	2,616	1,776
Goodwill	18,491	18,491
Intangible assets, net	15,825	28,389
Income tax deferred charge	11,581	13,102
Other assets:
Other	158	125
Total assets	214,977	174,205
Current liabilities:
Current portion of long-term debt	434	2,440
Current portion of long-term related party contingent consideration payable	28,614	39,892
Accounts payable	10,565	8,024
Deferred revenue	5,121	1,336
Accrued expenses	3,598	5,667
Income taxes	323	7,643
Other	133	5,672
Current liabilities held for sale	0	168
Total current liabilities	48,788	70,842
Long-term debt, less current portion	684	1,277
Long-term related party contingent consideration payable, less current portion	94,079	74,858
Deferred taxes	1,351	0
Other	2,210	2,333
Total liabilities	147,112	149,310
Shareholders' equity:
Ordinary shares, nominal value of 0.122 euro per share; 53,198 shares authorized; 41,241 and 40,191 issued and outstanding at December 31, 2015 and 2014, respectively	6,331	6,188
Additional paid-in capital	363,984	346,582
Accumulated deficit	(279,793)	(320,452)
Accumulated other comprehensive loss	(22,657)	(7,423)
Total shareholders' equity	67,865	24,895
Total liabilities and shareholders' equity	$ 214,977	$ 174,205